Effectiveness Evaluation of Additional Risk Minimization Measures for Adolescent Use of Aripiprazole in the European Union: Results from a Post-Authorization Safety Study

INTRODUCTION: Two risk minimization (RM) tools—a healthcare professional frequently asked questions (HCP-FAQs) brochure and a patient/caregiver information brochure (PCIB)—were developed for HCPs and for adolescents (aged ≥ 13 years) receiving aripiprazole for bipolar I mania and their caregivers. O...

Descripción completa

Detalles Bibliográficos
Autores principales: Landsberg, Wally, Al-Dakkak, Imad, Coppin-Renz, Antonia, Geis, Uli, Peters-Strickland, Timothy, van Heumen, Emiel, Rahman, Mirza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061424/
https://www.ncbi.nlm.nih.gov/pubmed/29671224
http://dx.doi.org/10.1007/s40264-018-0662-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6061424/
https://www.ncbi.nlm.nih.gov/pubmed/29671224
http://dx.doi.org/10.1007/s40264-018-0662-2

Ejemplares similares